Companies: 10,795·Total market cap: $144.5T
European Biotech Acquisition Corp.

European Biotech Acquisition Corp.

EBACNASDAQFinancial Services
$11.19
$-0.52(-4.44%)
Market Cap$183500312
P/E Ratio—
52W High$14.1
52W Low$9.282
Cash on HandFinancialsRevenue

European Biotech Acquisition Corp. (EBAC) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

EBAC · cash on hand · updated Dec 31, 2022

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$308,488▼ -64.5% vs prior year
FY · as of Dec 31, 2022 · Reported in USD
Cash & Cash Equiv. (CCE)
$308,488
cashAndCashEquivalents
Short-Term Investments
$0
shortTermInvestments
YoY Change vs Prior Year
-64.5%
vs prior fiscal year
Latest Quarter
$308,488
Q4 2022
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2022

Net cash vs debt

Cash & ST Investments$308,488Cash on Hand
Total Debt$0Total Debt
Net Cash / Net Debt+$308,488Net Cash Position
Cash vs Debt Ratio
Cash 100%Debt 0%

European Biotech Acquisition Corp. has a net cash position of $308,488, holding more cash than debt.

Net Cash = Cash & ST Investments − Total Debt$308,488 − $0 = +$308,488

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
EBAC annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Dec 31, 2022Latest$0.3M-64.5%
Dec 31, 2021$0.9M—
EBAC cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Financial Services Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
JPMorgan Chase & Co.
JPMorgan Chase & Co.
JPM
$1.48T177.5%#2
Berkshire Hathaway Inc.
Berkshire Hathaway Inc.
BRK-B
$373.31B35.5%#3
Visa Inc.
Visa Inc.
V
$21.99B3.6%#4
Mastercard Incorporated
Mastercard Incorporated
MA
$10.90B2.5%
#5
European Biotech Acquisition Corp.
European Biotech Acquisition Corp.YOU
EBAC
$0.3M0.2%
Financial Services sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

European Biotech Acquisition Corp. (EBAC) cash on hand as of December 31, 2022 is $308,488, comprising $308,488 in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as European Biotech Acquisition Corp. cash and short-term investments on the balance sheet (10-K filing). Also referred to as European Biotech Acquisition Corp. cash reserves or cash position.

European Biotech Acquisition Corp. annual cash on hand history shows decreased -64.5% in 2022: decreased -64.5% in 2022. European Biotech Acquisition Corp. cash reserves in 2022 reflect the company's capital allocation strategy.

European Biotech Acquisition Corp. carries total debt of $0 against cash of $308,488, resulting in a net cash position of +$308,488. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.
Financial statementsFree cash flowNet incomeRevenueMarket capP/E ratioEarningsPrice history

Frequently asked questions

EBAC cash on hand · 5 questions

As of December 31, 2022, European Biotech Acquisition Corp. (EBAC) has $308,488 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $308,488 in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (December 31, 2022): $308,488. Data sourced from the annual 10-K filing via FMP.

EBAC cash on handEBAC cash reservesEBAC cash 2022how much cash does EBAC have

▸ Source: FMP /balance-sheet-statement · US GAAP · European Biotech Acquisition Corp. · European Biotech Acquisition Corp. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2022